vs
Compass, Inc.（COMP）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
Compass, Inc.的季度营收约是瑞思迈的1.2倍（$1.7B vs $1.4B），瑞思迈净利率更高（27.6% vs -2.5%，领先30.1%），Compass, Inc.同比增速更快（23.1% vs 11.0%），瑞思迈自由现金流更多（$311.2M vs $42.2M），过去两年Compass, Inc.的营收复合增速更高（27.0% vs 9.0%）
Compass, Inc.是美国主营住宅房产经纪业务的企业，其平台旗下有约3.3万名经纪人，大多为独立合同工，运营Compass、21世纪不动产、科威国际不动产、苏富比国际地产、佳士得国际地产等多个知名房产经纪品牌。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
COMP vs RMD — 直观对比
营收规模更大
COMP
是对方的1.2倍
$1.4B
营收增速更快
COMP
高出12.2%
11.0%
净利率更高
RMD
高出30.1%
-2.5%
自由现金流更多
RMD
多$269.0M
$42.2M
两年增速更快
COMP
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.4B |
| 净利润 | $-42.6M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | -2.5% | 34.6% |
| 净利率 | -2.5% | 27.6% |
| 营收同比 | 23.1% | 11.0% |
| 净利润同比 | -5.2% | 13.9% |
| 每股收益（稀释后） | $-0.07 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COMPRMD
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.8B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.7B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
净利润COMPRMD
| Q4 25 | $-42.6M | $392.6M | ||
| Q3 25 | $-4.6M | $348.5M | ||
| Q2 25 | $39.4M | $379.7M | ||
| Q1 25 | $-50.7M | $365.0M | ||
| Q4 24 | $-40.5M | $344.6M | ||
| Q3 24 | $-1.7M | $311.4M | ||
| Q2 24 | $20.7M | $292.2M | ||
| Q1 24 | $-132.9M | $300.5M |
毛利率COMPRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率COMPRMD
| Q4 25 | -2.5% | 34.6% | ||
| Q3 25 | -0.4% | 33.4% | ||
| Q2 25 | 1.9% | 33.7% | ||
| Q1 25 | -4.0% | 33.0% | ||
| Q4 24 | -2.9% | 32.5% | ||
| Q3 24 | -0.2% | 31.6% | ||
| Q2 24 | 1.3% | 31.2% | ||
| Q1 24 | -12.5% | 31.3% |
净利率COMPRMD
| Q4 25 | -2.5% | 27.6% | ||
| Q3 25 | -0.2% | 26.1% | ||
| Q2 25 | 1.9% | 28.2% | ||
| Q1 25 | -3.7% | 28.3% | ||
| Q4 24 | -2.9% | 26.9% | ||
| Q3 24 | -0.1% | 25.4% | ||
| Q2 24 | 1.2% | 23.9% | ||
| Q1 24 | -12.6% | 25.1% |
每股收益（稀释后）COMPRMD
| Q4 25 | $-0.07 | $2.68 | ||
| Q3 25 | $-0.01 | $2.37 | ||
| Q2 25 | $0.07 | $2.58 | ||
| Q1 25 | $-0.09 | $2.48 | ||
| Q4 24 | $-0.08 | $2.34 | ||
| Q3 24 | $0.00 | $2.11 | ||
| Q2 24 | $0.04 | $1.97 | ||
| Q1 24 | $-0.27 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.0M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $782.0M | $6.3B |
| 总资产 | $1.5B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资COMPRMD
| Q4 25 | $199.0M | $1.4B | ||
| Q3 25 | $170.3M | $1.4B | ||
| Q2 25 | $177.3M | $1.2B | ||
| Q1 25 | $127.0M | $932.7M | ||
| Q4 24 | $223.8M | $521.9M | ||
| Q3 24 | $211.2M | $426.4M | ||
| Q2 24 | $185.8M | $238.4M | ||
| Q1 24 | $165.9M | $237.9M |
总债务COMPRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益COMPRMD
| Q4 25 | $782.0M | $6.3B | ||
| Q3 25 | $773.3M | $6.1B | ||
| Q2 25 | $719.9M | $6.0B | ||
| Q1 25 | $635.0M | $5.5B | ||
| Q4 24 | $409.4M | $5.3B | ||
| Q3 24 | $428.0M | $5.2B | ||
| Q2 24 | $398.4M | $4.9B | ||
| Q1 24 | $330.3M | $4.6B |
总资产COMPRMD
| Q4 25 | $1.5B | $8.5B | ||
| Q3 25 | $1.6B | $8.3B | ||
| Q2 25 | $1.6B | $8.2B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.2B | $7.1B | ||
| Q3 24 | $1.2B | $7.2B | ||
| Q2 24 | $1.2B | $6.9B | ||
| Q1 24 | $1.1B | $6.8B |
负债/权益比COMPRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.3M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | $311.2M |
| 自由现金流率自由现金流/营收 | 2.5% | 21.9% |
| 资本支出强度资本支出/营收 | 0.2% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $203.3M | $1.8B |
8季度趋势，按日历期对齐
经营现金流COMPRMD
| Q4 25 | $45.3M | $339.7M | ||
| Q3 25 | $75.5M | $457.3M | ||
| Q2 25 | $72.8M | $538.8M | ||
| Q1 25 | $23.1M | $578.7M | ||
| Q4 24 | $30.5M | $308.6M | ||
| Q3 24 | $37.4M | $325.5M | ||
| Q2 24 | $45.0M | $440.1M | ||
| Q1 24 | $8.6M | $402.0M |
自由现金流COMPRMD
| Q4 25 | $42.2M | $311.2M | ||
| Q3 25 | $73.6M | $414.4M | ||
| Q2 25 | $68.0M | $508.2M | ||
| Q1 25 | $19.5M | $557.9M | ||
| Q4 24 | $26.7M | $288.0M | ||
| Q3 24 | $32.8M | $307.7M | ||
| Q2 24 | $40.4M | $415.2M | ||
| Q1 24 | $5.9M | $380.8M |
自由现金流率COMPRMD
| Q4 25 | 2.5% | 21.9% | ||
| Q3 25 | 4.0% | 31.0% | ||
| Q2 25 | 3.3% | 37.7% | ||
| Q1 25 | 1.4% | 43.2% | ||
| Q4 24 | 1.9% | 22.5% | ||
| Q3 24 | 2.2% | 25.1% | ||
| Q2 24 | 2.4% | 33.9% | ||
| Q1 24 | 0.6% | 31.8% |
资本支出强度COMPRMD
| Q4 25 | 0.2% | 2.0% | ||
| Q3 25 | 0.1% | 3.2% | ||
| Q2 25 | 0.2% | 2.3% | ||
| Q1 25 | 0.3% | 1.6% | ||
| Q4 24 | 0.3% | 1.6% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.3% | 2.0% | ||
| Q1 24 | 0.3% | 1.8% |
现金转化率COMPRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | 1.85× | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | 2.17× | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COMP
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
